Friday, April 18, 2014
Let’s Play the Expensive Drug/Procedure Game
We make it impossible
for Americans legally to order their prescription drugs from other countries,
even when it is the same drug made by exactly the same company. Hard to justify
“quality-control” reasons for this wasteful, uncompetitive and malignant
restriction when it is exactly the same product.
So let’s play the game
with a little help from the April 17th Huffington Post, citing: “The latest
data from the International Federation of Health Plans, an industry group representing
health insurers from 28 countries including the United States, once again
illustrates that American patients pay the highest prices in the world for a
variety of prescription drugs and common procedures like childbirth and
hospital stays.” We’re not even going to look at the cheapest alternatives
(which would really shock you) to each of the following ailments/procedures… I
am simply going to give you the numbers for the second most expensive price in
the world (by country).
Acid Reflux. Common
Treatment, Nexium. Standard Prescription Cost Range in the United States ($196
to $395): average $215. Standard Prescription in New Zealand: $60.
Multiple Sclerosis.
Common Treatment, Copaxone. Standard Prescription Cost Range in the United
States ($3,875 to $4,018): average $3,903. Standard Prescription in
Switzerland: $1,357.
Common Treatment,
Gilenya. Standard Prescription Cost Range in the United States: ($4,169 to
$12,792): average $5,473. Standard Prescription in Canada: $2,541.
Leukemia. Common
Treatment for Some Form, Gleevec. Standard Prescription in the United States
($5,482 to $11,007): average $6,214. Standard Prescription in Switzerland:
$3,633.
Hospital Stay (Daily
Rate). Cost Range in the United States ($1447 to $12726): average $4293, New
Zealand average: $2,491.
By-Pass Surgery. Cost
Range in the United States ($47,982 to $151,886): average $75,345, Australia,
$42,130.
Hospital Delivery
(Physician and Hospital). Cost Range in the United States ($7,308 to $17,354):
average $10,002, Switzerland, $8,307.
When you are desperate,
facing a life and death moment, costs can literally kill you. “Prescription
drugs are particularly expensive in the U.S. relative to elsewhere in large
part because most other countries set prices for medicines through their
universal health care programs, which the U.S. doesn't have. This can hit
hardest for people, even those with health insurance, when they need the latest
medicines to treat serious diseases.
“Look at the price
differences in the U.S. for these big-ticket prescription drugs, which are
about twice as expensive in America as in the next-highest country and much
more so than in the lowest-cost nations… And despite the persistent claims by
nearly anyone holding or seeking public office in the U.S. that America has the
best health care system in the world, there's scant evidence that we're getting
higher-quality medical treatment or enjoying healthier lives than our
counterparts abroad. What's more, the U.S. still leaves tens of millions of its
own citizens without health coverage, and will continue to do so even a decade
into the implementation of Obamacare.” Huffington Post.
We rank 80th on a
global scale measuring a mix of quality of healthcare with relative access to
the system. There are 33 countries with better infant mortality rates than we
have. There are 34 nations with longer average life expectancies than do we.
When Obamacare passed, any semblance of creating competitive low cost
components – from a government low cost insurance alternative (like Medicare)
to allowing access to cheaper prescriptions from overseas – were crushed by
powerful industry lobbyists whose jingling cash-hints of campaign contributions
made the difference.
Think all this won’t
impact your actual treatments? Bottom line, if a treatment is likely to work
(and you desperately need it) but it’s too expensive, your health and life just
might not be worth saving even if you have coverage. Folks are seriously
thinking about how to apply cost-savings to expensive treatments. “Saying they
can no longer ignore the rising prices of health care, some of the most
influential medical groups in the nation are recommending that doctors weigh
the costs, not just the effectiveness of treatments, as they make decisions about
patient care.
“The shift, little
noticed outside the medical establishment but already controversial inside it,
suggests that doctors are starting to redefine their roles, from being
concerned exclusively about individual patients to exerting influence on how
health care dollars are spent… ‘We understand that we doctors should be and are
stewards of the larger society as well as of the patient in our examination
room,’ said Dr. Lowell E. Schnipper, the chairman of a task force on value in
cancer care at the American Society of Clinical Oncology.
“In practical terms,
new guidelines being developed by the medical groups could result in doctors
choosing one drug over another for cost reasons or even deciding that a
particular treatment — at the end of life, for example — is too expensive. In
the extreme, some critics have said that making treatment decisions based on
cost is a form of rationing.” New York Times, April 17th. Death panel, anyone?
For example, there is a new highly effective treatment for Hepatitis C, but
costs an average of $84,000 to administer. Want to pay for that under Medicaid,
Medicare or expect easy coverage under a pile of lower-end insurance policies?
See a battle looming?
And every year, medical
costs rise faster than the average worker’s pay rises. Every year for well-over
a decade, the buying power for average Americans has fallen. The medical cost
lines are going to cross the affordability line at this pace, sooner rather
than later. We’re close to that even now. Most of us won’t even be able to
afford the deeply discounted, often government subsidized cost of Obamacare.
Then what? Why do we begin to solve problems when it’s too late to do it
intelligently and effectively? Because incumbents with money want it that way.
I’m
Peter Dekom, and we are way too blasé about life and death issues that really
impact our daily lives… like financial regulations to prevent collapse or
really addressing environmental quality and healthcare… but that’s okay, it
only hurts our children and grandchildren, so who cares?
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment